Literature DB >> 25577211

Biomechanical properties of hybrid heart valve prosthesis utilizing the pigs that do not express the galactose-α-1,3-galactose (α-Gal) antigen derived tissue and tissue engineering technique.

Piotr Wilczek1, Anna Lesiak, Aleksandra Niemiec-Cyganek, Barbara Kubin, Ryszard Slomski, Jerzy Nozynski, Grazyna Wilczek, Aldona Mzyk, Michalina Gramatyka.   

Abstract

The aim of the study was to estimate the biomechanical properties of heart valves conduit derived from transgenic pigs to determine the usefulness for the preparation of tissue-engineered heart valves. The acellular aortic and pulmonary valve conduits from transgenic pigs were used to estimate the biomechanical properties of the valve. Non-transgenic porcine heart valve conduits were used as a reference. The biomechanics stability of acellular valve conduits decreased both for the transgenic and non-transgenic porcine valves. The energy required to break the native pulmonary valve derived from transgenic pigs was higher (20,475 ± 7,600 J m(-2)) compared with native non-transgenic pigs (12,140 ± 5,370 J m(-2)). After acellularization, the energy to break the valves decreased to 14,600 and 8,800 J m(-2) for the transgenic pulmonary valve and non-transgenic valve, respectively. The native transgenic pulmonary valve showed a higher extensibility (42.70 %) than the non-transgenic pulmonary valve (35.50 %); the extensibility decreased after acellularization to 41.1 and 31.5 % for the transgenic and non-transgenic valves, respectively. The pulmonary valves derived from transgenic pigs demonstrate better biomechanical properties compared with non-transgenic. Heart valves derived from transgenic pigs can be valuable for the preparation of tissue-engineered bioprostheses, because of their biomechanical properties, stability, reduced immune response, making them safer for clinical applications.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25577211     DOI: 10.1007/s10856-014-5329-7

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  32 in total

1.  Functional living trileaflet heart valves grown in vitro.

Authors:  S P Hoerstrup; R Sodian; S Daebritz; J Wang; E A Bacha; D P Martin; A M Moran; K J Guleserian; J S Sperling; S Kaushal; J P Vacanti; F J Schoen; J E Mayer
Journal:  Circulation       Date:  2000-11-07       Impact factor: 29.690

2.  Biomatrix/polymer composite material for heart valve tissue engineering.

Authors:  Christof Stamm; Amir Khosravi; Niels Grabow; Kathleen Schmohl; Nadine Treckmann; Anne Drechsel; Ma Nan; Klaus-Peter Schmitz; Axel Haubold; Gustav Steinhoff
Journal:  Ann Thorac Surg       Date:  2004-12       Impact factor: 4.330

Review 3.  Prosthetic heart valves.

Authors:  W Vongpatanasin; L D Hillis; R A Lange
Journal:  N Engl J Med       Date:  1996-08-08       Impact factor: 91.245

4.  Decellularization of bovine pericardium for tissue-engineering by targeted removal of xenoantigens.

Authors:  Ana C Gonçalves; Leigh G Griffiths; Russell V Anthony; E Christopher Orton
Journal:  J Heart Valve Dis       Date:  2005-03

5.  Bioprosthetic heart valve failure: pathology and pathogenesis.

Authors:  F J Schoen; R J Levy
Journal:  Cardiol Clin       Date:  1984-11       Impact factor: 2.213

6.  Aortic valve replacement with pulmonary homografts. Early experience.

Authors:  G Gerosa; D N Ross; P E Brucke; A Dziatkowiak; S Mohammad; D Norman; J Davies; A Sbarbati; D Casarotto
Journal:  J Thorac Cardiovasc Surg       Date:  1994-02       Impact factor: 5.209

7.  Effects of decellularization on the mechanical and structural properties of the porcine aortic valve leaflet.

Authors:  Jun Liao; Erinn M Joyce; Michael S Sacks
Journal:  Biomaterials       Date:  2008-03       Impact factor: 12.479

8.  Lack of galactose-alpha-1,3-galactose expression on porcine endothelial cells prevents complement-induced lysis but not direct xenogeneic NK cytotoxicity.

Authors:  Bettina C Baumann; Pietro Forte; Robert J Hawley; Robert Rieben; Mårten K J Schneider; Jörg D Seebach
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

9.  Early failure of the tissue engineered porcine heart valve SYNERGRAFT in pediatric patients.

Authors:  P Simon; M T Kasimir; G Seebacher; G Weigel; R Ullrich; U Salzer-Muhar; E Rieder; E Wolner
Journal:  Eur J Cardiothorac Surg       Date:  2003-06       Impact factor: 4.191

10.  Effect of decellularization protocol on the mechanical behavior of porcine descending aorta.

Authors:  John C Fitzpatrick; Peter M Clark; Franco M Capaldi
Journal:  Int J Biomater       Date:  2010-07-04
View more
  3 in total

1.  Antigenicity of tissues and organs from GGTA1/CMAH/β4GalNT2 triple gene knockout pigs.

Authors:  Rong-Gen Wang; Miaomiao Ruan; Run-Jie Zhang; Lei Chen; Xiao-Xue Li; Bin Fang; Chu Li; Xue-Yang Ren; Ji-Ying Liu; Qiang Xiong; Li-Ning Zhang; Yong Jin; Lin Li; Rongfeng Li; Ying Wang; Hai-Yuan Yang; Yi-Fan Dai
Journal:  J Biomed Res       Date:  2018-07-11

2.  Biomechanical and morphological stability of acellular scaffolds for tissue-engineered heart valves depends on different storage conditions.

Authors:  Piotr Wilczek; Gach Paulina; Jendryczko Karolina; Marcisz Martyna; Wilczek Grazyna; Major Roman; Mzyk Aldona; Sypien Anna; Samotus Aneta
Journal:  J Mater Sci Mater Med       Date:  2018-07-03       Impact factor: 3.896

Review 3.  Characteristics of α-Gal epitope, anti-Gal antibody, α1,3 galactosyltransferase and its clinical exploitation (Review).

Authors:  Guoli Huai; Ping Qi; Hongji Yang; Yi Wang
Journal:  Int J Mol Med       Date:  2015-10-30       Impact factor: 4.101

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.